Factors associated with treatment for hypotension in extremely low gestational age newborns during the first

Matthew Laughon1, Carl Bose, Elizabeth Allred

  • 1School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. matt_laughon@med.unc.edu

Pediatrics
|February 3, 2007
PubMed

Insights

Treatment decisions for extremely premature infants

Area of Science:

  • Neonatology
  • Pediatric Critical Care
  • Perinatal Medicine

Background:

  • Extremely low gestational age newborns (ELGANs) often experience hypotension.
  • Management of hypotension in ELGANs lacks standardized treatment thresholds.
  • Interinstitutional variability exists in the treatment of hypotension in ELGANs.

Purpose of the Study:

  • Identify blood pressure thresholds for intervention in ELGANs.
  • Determine infant characteristics associated with hypotension treatment.
  • Assess variability in hypotension treatment practices across institutions.

Main Methods:

  • Retrospective cohort study of 1507 ELGANs (23-27 weeks gestation) at 14 institutions.
  • Blood pressures monitored clinically; interventions categorized as any treatment or vasopressor treatment.
  • Logistic regression analyses used to identify factors associated with treatment.

Main Results:

  • Hypotension treatment varied significantly between institutions, independent of infant factors.
  • Lower gestational age, lower birth weight, male gender, and higher illness severity scores were associated with increased treatment.
  • Treatment initiation predominantly occurred within the first 24 hours of life.

Conclusions:

  • Blood pressure in untreated ELGANs increases with gestational and postnatal age.
  • Treatment decisions for hypotension in ELGANs are strongly influenced by the care institution, not solely by infant characteristics.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors: